[1]
M. A. Yenikomshian, MBA, “Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients”, J of Opioid Management, vol. 13, no. 5, pp. 291–301, Sep. 2017.